ACCENDRA HEALTH INC/VA/
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.8 | $2.7 | $2.6 | $10.0 | $9.8 |
| Operating income | $<0.1 | -$0.2 | $0.1 | $0.1 | $0.4 |
| Net income | -$1.1 | -$0.4 | -$<0.1 | $<0.1 | $0.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$0.3 | -$<0.1 | $0.6 | $0.2 | $0.1 |
| Dividends | — | — | $0.0 | $0.0 | $<0.1 |
| Share repurchases | $<0.1 | — | — | — | — |
Shares outstanding 76.9M · Free float 32.2%
Annual filing data through FY ended December 31, 2025; float as of September 17, 2026.